Roberts C J, Birkenmeier T M, McQuillan J J, Akiyama S K, Yamada S S, Chen W T, Yamada K M, McDonald J A
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.
J Biol Chem. 1988 Apr 5;263(10):4586-92.
Transforming growth factors of the beta-class (TGFs-beta) stimulate extracellular matrix synthesis and have been implicated in embryogenesis, wound healing, and fibroproliferative responses to tissue injury. Because cells communicate with several extracellular matrix components via specific cell membrane receptors, we hypothesized that TGFs-beta may also regulate the expression of such receptors. We confirmed that TGF-beta 1 increases the expression of fibronectin, an adhesive glycoprotein expressed during embryogenesis and tissue remodeling. Based upon the 48-72-h period required for a maximal fibroproliferative response to dermal injections of TGF-beta 1, we exposed human fetal lung fibroblasts (IMR-90) to TGF-beta 1 for periods up to 48 h in vitro. We observed as much as 6-fold increases in fibronectin synthesis by 24 h as previously reported for fibroblastic cells (Ignotz, R. A., and Massagué, J. (1986) J. Biol. Chem. 261, 4337-4345; Ignotz, R. A., Endo, T., and Massagué, J. (1987) J. Biol. Chem. 262, 6443-6446; Raghow, R., Postlethwaithe, A. E., Keski-Oja, J., Moses, H. L., and Kang, A. H. (1987) J. Clin. Invest. 79, 1285-1288), but up to 30-fold increases by 48 h. These increases are accompanied by similar increases in fibronectin mRNA levels which are prevented by actinomycin D treatment. Using a monospecific antibody raised to the human placental fibronectin receptor complex, we found that TGF-beta 1 stimulated fibronectin receptor synthesis up to 20-40-fold and increases mRNA levels encoding both the alpha- and beta-subunits up to 3-fold, compared to control IMR-90 in serum-free medium. Actinomycin D blocks TGF-beta 1-mediated increases in receptor mRNA levels. The earliest detectable TGF-beta 1-mediated increases in fibronectin receptor complex protein synthesis and mRNA levels occur at 8 h, whereas the earliest increases in fibronectin protein synthesis and mRNA levels occur at 12 h. These results demonstrate that TGF-beta 1 stimulates fibronectin receptor synthesis, extending the diverse stimulatory activities of this polypeptide to matrix receptors. In addition, because fibronectin matrix assembly may involve the fibronectin cell adhesive receptor complex, increased receptor expression may help drive fibronectin deposition into matrix.
β类转化生长因子(TGF-β)可刺激细胞外基质合成,并与胚胎发育、伤口愈合以及对组织损伤的纤维增生反应有关。由于细胞通过特定细胞膜受体与多种细胞外基质成分进行通讯,我们推测TGF-β也可能调节此类受体的表达。我们证实,TGF-β1可增加纤连蛋白的表达,纤连蛋白是一种在胚胎发育和组织重塑过程中表达的黏附糖蛋白。基于对真皮注射TGF-β1产生最大纤维增生反应所需的48 - 72小时,我们将人胎儿肺成纤维细胞(IMR-90)在体外暴露于TGF-β1长达48小时。我们观察到,到24小时时纤连蛋白合成增加了6倍,这与之前报道的成纤维细胞情况相同(Ignotz,R. A.和Massagué,J.(1986年)《生物化学杂志》261卷,4337 - 4345页;Ignotz,R. A.,Endo,T.和Massagué,J.(1987年)《生物化学杂志》262卷,6443 - 6446页;Raghow,R.,Postlethwaithe,A. E.,Keski-Oja,J.,Moses,H. L.和Kang,A. H.(1987年)《临床研究杂志》79卷,1285 - 1288页),但到48小时时增加了30倍。这些增加伴随着纤连蛋白mRNA水平的类似增加,而放线菌素D处理可阻止这种增加。使用针对人胎盘纤连蛋白受体复合物产生的单特异性抗体,我们发现与无血清培养基中的对照IMR-90相比,TGF-β1刺激纤连蛋白受体合成增加了20 - 40倍,并使编码α和β亚基的mRNA水平增加了3倍。放线菌素D可阻断TGF-β1介导的受体mRNA水平增加。最早可检测到的TGF-β1介导的纤连蛋白受体复合物蛋白合成和mRNA水平增加发生在8小时,而纤连蛋白蛋白合成和mRNA水平最早增加发生在12小时。这些结果表明,TGF-β1刺激纤连蛋白受体合成,将该多肽的多种刺激活性扩展到基质受体。此外,由于纤连蛋白基质组装可能涉及纤连蛋白细胞黏附受体复合物,受体表达增加可能有助于驱动纤连蛋白沉积到基质中。